Osteoporosis Fracture: Clinical Trials

4 trials for Osteoporosis Fracture, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 active not recruiting, 1 not yet recruiting. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Unknown 2, Active not recruiting 1, Not yet recruiting 1

Follow Osteoporosis Fracture: new trials by email Literature Review of Osteoporosis Fracture trials Research Report on Osteoporosis Fracture

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Semaglutide on Bone Health
semaglutide combined with metformin - Osteoporosis, Osteoporosis Fracture
Phase 4Not yet recruitingThe First Affiliated Hospital of Xiamen University1502025-09-152025-09-17
Romosozumab Use to Build Skeletal Integrity
Romosozumab, Placebo, Zoledronic acid - Osteoporosis, Osteoporosis, Postmenopausal
Phase 4Active not recruitingSusan L. Greenspan1842021-09-152026-02-17
Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density
Romosozumab, Zoledronic Acid - Osteoporosis Fracture, Spinal Cord Injuries
Phase 4UnknownSheba Medical Center302020-11-012020-10-22
Breast Cancer Women on Aromatase Inhibitors Treatment
bisphosphonate - Osteoporosis, Osteoporosis Fracture
Phase 4UnknownParc de Salut Mar10002016-01-012019-01-28

Narrower conditions

Osteoporotic Fractures (4)  ·  Osteoporosis (3)  ·  Arthralgia (1)  ·  Bone Diseases, Metabolic (1)  ·  Breast Neoplasms (1)  ·  Fractures, Bone (1)  ·  Musculoskeletal Pain (1)  ·  Osteoporosis, Postmenopausal (1)  ·  Spinal Cord Injuries (1)

Broader conditions

Wounds and Injuries (4)  ·  Bone Diseases (3)  ·  Fractures, Bone (3)  ·  Metabolic Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Bone Diseases, Metabolic (2)  ·  Breast Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Joint Diseases (1)  ·  Muscular Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)

Interventions

Zoledronic Acid (2)  ·  romosozumab (2)  ·  Calcium (1)  ·  Denosumab (1)  ·  Diphosphonates (1)  ·  Metformin (1)  ·  Vitamin D (1)

Sponsors

Parc de Salut Mar (1)  ·  Sheba Medical Center (1)  ·  Susan L. Greenspan (1)  ·  The First Affiliated Hospital of Xiamen University (1)

Countries

China (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Liana Tripto-Shkolnik, MD (1)  ·  Susan L Greenspan, MD (1)

Results publications

PMID 26327926, PMID 31127467

NIH funding

R01AG066825 (1)